Table 5. Cox multivariate analysis of the correlation between clinicopathological parameters and survival time of patients with NSCLC (including combined expression of CALR and PDIA3).
Wald | df | P | Exp(B) | 95.0% CI for Exp(B) | ||
---|---|---|---|---|---|---|
Lower | Upper | |||||
Gender (Male vs. Female) | 1.241 | 1 | 0.265 | 1.345 | 0.798 | 2.266 |
Age (< 62 vs. ≥ 62) | 0.540 | 1 | 0.462 | 0.816 | 0.474 | 1.403 |
Pathological grades (I + I–II + II vs. II–III + III) | 0.560 | 1 | 0.454 | 0.795 | 0.435 | 1.451 |
AJCC stages (I vs. II + III) | 13.025 | 1 | 0.000 | 3.002 | 1.653 | 5.454 |
Combined expression of CALR and PDIA3 | ||||||
Low PDIA3 and low CALR | 12.148 | 3 | 0.007 | |||
Low PDIA3 and high CALR | 6.792 | 1 | 0.009 | 0.340 | 0.151 | 0.765 |
High PDIA3 and low CALR | 3.202 | 1 | 0.074 | 0.427 | 0.168 | 1.085 |
High PDIA3 and high CALR | 11.331 | 1 | 0.001 | 0.337 | 0.179 | 0.635 |
Cases of group “–” and “+” were assigned to group low. Cases of group “++” and “+++” were assigned to group high.